许慧, 申采奕, 秦子健, 高映宁, 王敏. 甘露糖的临床应用研究进展[J]. 实用临床医药杂志, 2021, 25(14): 103-107. DOI: 10.7619/jcmp.20210814
引用本文: 许慧, 申采奕, 秦子健, 高映宁, 王敏. 甘露糖的临床应用研究进展[J]. 实用临床医药杂志, 2021, 25(14): 103-107. DOI: 10.7619/jcmp.20210814
XU Hui, SHEN Caiyi, QIN Zijian, GAO Yingning, WANG Min. Research progress of mannose's clinical application[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 103-107. DOI: 10.7619/jcmp.20210814
Citation: XU Hui, SHEN Caiyi, QIN Zijian, GAO Yingning, WANG Min. Research progress of mannose's clinical application[J]. Journal of Clinical Medicine in Practice, 2021, 25(14): 103-107. DOI: 10.7619/jcmp.20210814

甘露糖的临床应用研究进展

Research progress of mannose's clinical application

  • 摘要: 甘露糖是一种蛋白质糖基化单糖,分子式为C6H12O6,具有干扰葡萄糖代谢、抑制脂肪沉积、调节肠道菌群、参与免疫调节等作用。全面了解甘露糖治疗相关疾病的作用机制是拓展其临床应用的关键。本研究对近年来甘露糖在抗肿瘤、尿路感染、肥胖、糖尿病等方面的研究进展进行综述,探讨其作用机制与应用前景,以期为拓展甘露糖的临床应用提供理论支持。

     

    Abstract: Mannose is a protein glycosylated monosaccharide with molecular formula C6H12O6, and it can interfere with glucose metabolism, inhibit fat deposition, regulate intestinal flora and participate in immune regulation. Comprehensive understanding of the mechanism of mannose in the treatment of related diseases is the key to expand its clinical application. In this study, we reviewed the research progress of mannose in anti-tumor, urinary tract infection, obesity, diabetes and other aspects in recent years, explored its mechanism and application prospect, hoping to provide theoretical supports for expanding the clinical application of mannose.

     

/

返回文章
返回